Related references
Note: Only part of the references are listed.Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2020
DIABETES CARE (2020)
A Systematic Review of Cost-Effectiveness of Sodium-Glucose Cotransporter Inhibitors for Type 2 Diabetes
Yilin Yoshida et al.
CURRENT DIABETES REPORTS (2020)
Contemporary Treatment Patterns and Clinical Outcomes of Comorbid Diabetes Mellitus and HFrEF The CHAMP-HF Registry
Muthiah Vaduganathan et al.
JACC-HEART FAILURE (2020)
2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes
Sandeep R. Das et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
Milton Packer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Dapagliflozin in Patients with Chronic Kidney Disease
Hiddo J. L. Heerspink et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Racial, Ethnic, and Socioeconomic Inequities in the Prescription of Direct Oral Anticoagulants in Patients With Venous Thromboembolism in the United States
Ashwin S. Nathan et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2019)
Sodium Glucose Co-transporter 2 Inhibitors and Heart Failure
Raktim K. Ghosh et al.
AMERICAN JOURNAL OF CARDIOLOGY (2019)
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
J. J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Identification of Racial Inequities in Access to Specialized Inpatient Heart Failure Care at an Academic Medical Center
Lauren A. Eberly et al.
CIRCULATION-HEART FAILURE (2019)
Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2019
William T. Cefalu et al.
DIABETES CARE (2019)
Widening Racial Differences in Risks for Coronary Heart Disease
Wilson Nadruz et al.
CIRCULATION (2018)
African Americans Are Less Likely to Receive Care by a Cardiologist During an Intensive Care Unit Admission for Heart Failure
Khadijah Breathett et al.
JACC-HEART FAILURE (2018)
2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease
Sandeep R. Das et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Gender Differences in Patient-Reported Outcomes Among Adults With Atherosclerotic Cardiovascular Disease
Victor Okunrintemi et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation Findings From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II
Utibe R. Essien et al.
JAMA CARDIOLOGY (2018)
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Bruce Neal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS2 to the CHA2DS2-VASc Score for Thromboembolic Risk Assessment Analysis From the National Cardiovascular Data Registry's Outpatient Practice Innovation and Clinical Excellence Atrial Fibrillation Registry
David F. Katz et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2017)
Heart Disease and Stroke Statistics-2017 Update A Report From the American Heart Association
Emelia J. Benjamin et al.
CIRCULATION (2017)
Racial and Ethnic Differences in Heart Failure Readmissions and Mortality in a Large Municipal Healthcare System
Matthew S. Durstenfeld et al.
JACC-HEART FAILURE (2016)
Probing SGLT2 as a therapeutic target for diabetes: Basic physiology and consequences
Linda A. Gallo et al.
DIABETES & VASCULAR DISEASE RESEARCH (2015)
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Recent Declines in Hospitalizations for Acute Myocardial Infarction for Medicare Fee-for-Service Beneficiaries Progress and Continuing Challenges
Jersey Chen et al.
CIRCULATION (2010)
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
N. Sarwar et al.
LANCET (2010)
The public health critical race methodology: Praxis for antiracism research
Chandra L. Ford et al.
SOCIAL SCIENCE & MEDICINE (2010)
White/Black Racial Differences in Risk of End-stage Renal Disease and Death
Andy I. Choi et al.
AMERICAN JOURNAL OF MEDICINE (2009)
Differences in Specialist Consultations for Cardiovascular Disease by Race, Ethnicity, Gender, Insurance Status, and Site of Primary Care
Nakela L. Cook et al.
CIRCULATION (2009)
Racial Differences in Incident Heart Failure among Young Adults
Kirsten Bibbins-Domingo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Heart failure incidence and survival (from the atherosclerosis risk in communities study)
Laura R. Loehr et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
US disparities in health: Descriptions, causes, and mechanisms
Nancy E. Adler et al.
ANNUAL REVIEW OF PUBLIC HEALTH (2008)
NHS heart failure survey: a survey of acute heart failure admissions in England, Wales and Northern Ireland
E. D. Nicol et al.
HEART (2008)
Longitudinal study of racial and ethnic differences in developing end-stage renal disease among aged medicare beneficiaries
Jay L. Xue et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
State of disparities in cardiovascular health in the United States
GA Mensah et al.
CIRCULATION (2005)
Asian Americans' reports of their health care experiences - Results of a national survey
Q Ngo-Metzger et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2004)
The 'real' woman with heart failure. Impact of sex on current in-hospital management of heart failure by cardiologists and internists
C Opasich et al.
EUROPEAN JOURNAL OF HEART FAILURE (2004)
Ethnic and racial differences in diabetes care
DE Bonds et al.
DIABETES CARE (2003)
Racial variation in the control of diabetes among elderly Medicare managed care beneficiaries
AM McBean et al.
DIABETES CARE (2003)
Racial disparities in diabetes care processes, outcomes, and treatment intensity
M Heisler et al.
MEDICAL CARE (2003)
Excess risk of chronic kidney disease among African-American versus white subjects in the United States:: A population-based study of potential explanatory factors
ME Tarver-Carr et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
Diabetes and atherosclerosis - Epidemiology, pathophysiology, and management
JA Beckman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Underutilisation of ACE inhibitors in patients with congestive heart failure
TJ Bungard et al.
DRUGS (2001)
Quality of diabetes care in community health centers
MH Chin et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2000)
Share Paper
